14th week of 2017 patent applcation highlights part 16 |
Patent application number | Title | Published |
20170096391 | NOVEL LACTAMS | 2017-04-06 |
20170096392 | AROMATIC HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL APPLICATIONS THEREOF | 2017-04-06 |
20170096393 | NOVEL BIS-INDOLYLMETHANES, A PROCESS FOR THEIR PREPARATION AND USES THEREOF | 2017-04-06 |
20170096394 | DESIGN, SYNTHESIS AND CHARACTERIZATION OF METAL ORGANIC FRAMEWORKS | 2017-04-06 |
20170096395 | NOVEL POLYMORPHS OF CABOZANTINIB (S)-MALATE AND CABOZANTINIB FREE BASE | 2017-04-06 |
20170096396 | PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | 2017-04-06 |
20170096397 | Industrial Process for Making an Ivacaftor and its Intermediates | 2017-04-06 |
20170096398 | NON-HYGROSCOPIC SALTS OF 5-HT2C AGONISTS | 2017-04-06 |
20170096399 | PYRAZOLE COMPOUNDS AND THEIR USE AS T-TYPE CALCIUM CHANNEL BLOCKERS | 2017-04-06 |
20170096400 | ALKYNYL INDAZOLE DERIVATIVE AND USE THEREOF | 2017-04-06 |
20170096401 | IMIDAZOLE DERIVATIVES AS FORMYL PEPTIDE RECEPTOR MODULATORS | 2017-04-06 |
20170096402 | 5-(HETERO)ARYLPYRIDAZINONES AND THEIR USE AS HERBICIDES | 2017-04-06 |
20170096403 | PYRIMIDINE HYDROXY AMIDE COMPOUNDS AS PROTEIN DEACETYLASE INHIBITORS AND METHODS OF USE THEREOF | 2017-04-06 |
20170096404 | DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS | 2017-04-06 |
20170096405 | NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | 2017-04-06 |
20170096406 | Dual Inhibitor Compounds for Use in the Treatment of Neurodegenerative Disorders and Alzheimer's Disease | 2017-04-06 |
20170096407 | CATALYST RECYCLE METHODS | 2017-04-06 |
20170096408 | POLYCYCLOCARBONATE COMPOUNDS AND POLYMERS FORMED THEREFROM | 2017-04-06 |
20170096409 | 2,3-Disubstituted Pyridine Compounds as TGF-Beta Inhibitors and Methods of Use | 2017-04-06 |
20170096410 | ANTIFUNGAL COMPOUND PROCESS | 2017-04-06 |
20170096411 | HETEROCYCLIC COMPOUNDS USEFUL AS PIM KINASE INHIBITORS | 2017-04-06 |
20170096412 | Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity | 2017-04-06 |
20170096413 | PYRIMIDINE HYDROXY AMIDE COMPOUNDS AS HDAC6 SELECTIVE INHIBITORS | 2017-04-06 |
20170096414 | ALKYLATION OF PICOLINAMIDES WITH SUBSTITUTED CHLOROACYLALS UTILIZING A CROWN ETHER CATALYST | 2017-04-06 |
20170096415 | BIFUNCTIONAL MOLECULES WITH ANTIBODY-RECRUITING AND ENTRY INHIBITORY ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS | 2017-04-06 |
20170096416 | PYRAZOLE-SUBSTITUTED ARYLAMIDES AS P2X3 AND P2X2/3 ANTAGONISTS | 2017-04-06 |
20170096417 | Multicyclic Compounds And Methods Of Using Same | 2017-04-06 |
20170096418 | COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | 2017-04-06 |
20170096419 | HETEROCYCLE-SUBSTITUTED PYRIDYL BENZOTHIOPHENES AS KINASE INHIBITORS | 2017-04-06 |
20170096420 | OPTICALLY ACTIVE PDE10 INHIBITOR | 2017-04-06 |
20170096421 | Carboxamide Derivatives and Use Thereof | 2017-04-06 |
20170096422 | HETEROCYCLIC COMPOUND | 2017-04-06 |
20170096423 | ANTAGONISTS ACTING AT MULTIPLE PROSTAGLANDIN RECEPTORS FOR THE TREATMENT OF INFLAMMATION | 2017-04-06 |
20170096424 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | 2017-04-06 |
20170096425 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | 2017-04-06 |
20170096426 | Novel Tricyclic Modulators of Cannabinoid Receptors | 2017-04-06 |
20170096427 | FLUORINATED 3-(2-OXO-3-(3-ARYLPROPYL)IMIDAZOLIDIN-1-YL)-3-ARYLPROPANOIC ACID DERIVATIVES | 2017-04-06 |
20170096428 | Novel Cyclopropabenzofuranyl Pyridopyrazinediones | 2017-04-06 |
20170096429 | MACROCYCLES WITH AROMATIC P2' GROUPS AS FACTOR XIA INHIBITORS | 2017-04-06 |
20170096430 | COMPOSITIONS AND METHODS FOR INHIBITING BETA-LACTAMASE | 2017-04-06 |
20170096431 | 7-BENZYL-4-(2-METHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZO [1,2-A]PYRIDO[3,4-E]PYRIMIDIN-5(1H)-ONE, ANALOGS THEREOF, AND SALTS THEREOF AND METHODS FOR THEIR USE IN THERAPY | 2017-04-06 |
20170096432 | (5,6-DIHYDRO)PYRIMIDO[4,5-E]INDOLIZINES | 2017-04-06 |
20170096433 | HELQUATS WITH HETEROAROMATIC SUBSTITUENTS, PREPARATION THEREOF, AND USE THEREOF AS G-QUADRUPLEX STABILIZERS | 2017-04-06 |
20170096434 | DERIVATIZED CORROLES AND METALLOCORROLES AND THEIR USE AS IMAGING AND THERAPEUTIC AGENTS | 2017-04-06 |
20170096435 | SEPIAPTERIN REDUCTASE INHIBITORS | 2017-04-06 |
20170096436 | COMPOUNDS FOR TREATMENT OF FLUOROQUINOLONE-RESISTANT BACTERIA | 2017-04-06 |
20170096437 | MUSCARINIC RECEPTOR AGONISTS | 2017-04-06 |
20170096438 | Method for the Preparation of Functionalized Cyclosiloxanes | 2017-04-06 |
20170096439 | INCLUSION COMPOUND OF 3',5'-CYCLICDIADENYLIC ACID, AND METHOD FOR PRODUCING SAME | 2017-04-06 |
20170096440 | NOVEL ACTIVATORS OF GLUCOKINASE | 2017-04-06 |
20170096441 | PHOSPHONATES WITH REDUCED TOXICITY FOR TREATMENT OF VIRAL INFECTIONS | 2017-04-06 |
20170096442 | Crystalline Forms of Fosnetupitant | 2017-04-06 |
20170096443 | PLATINUM(IV) COMPOUNDS AND METHODS OF MAKING AND USING SAME | 2017-04-06 |
20170096444 | MINIMAL SAPONIN ANALOGUES, SYNTHESIS AND USE THEREOF | 2017-04-06 |
20170096445 | PROCESS FOR THE PREPARATION OF MACROLIDE ANTIBACTERIAL AGENTS | 2017-04-06 |
20170096446 | Extended Triterpene Derivatives | 2017-04-06 |
20170096447 | CONTROL APPARATUS FOR DISPENSING SMALL PRECISE AMOUNTS OF LIQUID REAGENTS | 2017-04-06 |
20170096448 | SYSTEMS AND METHODS FOR EXCHANGE OF BUFFER SOLUTIONS | 2017-04-06 |
20170096449 | Compositions and Methods Relating to Ionic Salts of Peptides | 2017-04-06 |
20170096450 | Dipeptide Comprising a Non-Proteogenic Amino Acid | 2017-04-06 |
20170096451 | INHIBITION OF GLIADIN PEPTIDES | 2017-04-06 |
20170096452 | Novel Tumor-Targeting Compounds | 2017-04-06 |
20170096453 | TEMPLATE-FIXED PEPTIDOMIMETICS | 2017-04-06 |
20170096454 | CYCLOHEPTAPEPTIDE AGENTS FOR TREATMENT OF CANCER AND OBESITY DISEASES | 2017-04-06 |
20170096455 | METHODS AND COMPOSITIONS FOR CHIMERIC CORONAVIRUS SPIKE PROTEINS | 2017-04-06 |
20170096456 | IMMUNOGENIC HPV L2-CONTAINING VLPS AND RELATED COMPOSITIONS, CONSTRUCTS, AND THERAPEUTIC METHODS | 2017-04-06 |
20170096457 | ANTI-INFLAMMATORY COMPOUNDS AND METHODS OF USE | 2017-04-06 |
20170096458 | CYAA-BASED CHIMERIC PROTEINS COMPRISING A HETEROLOGOUS POLYPEPTIDE AND THEIR USES IN THE INDUCTION OF IMMUNE RESPONSES | 2017-04-06 |
20170096459 | PEPTIDE TAGS FOR LABELING PROTEINS BY FUSION, AND ANTIBODIES FOR THE DETECTION THEREOF | 2017-04-06 |
20170096460 | HTT REPRESSORS AND USES THEREOF | 2017-04-06 |
20170096461 | Novel peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers | 2017-04-06 |
20170096462 | CHIMERIC FGF21 PROTEINS WITH ENHANCED BINDING AFFINITY FOR BETA-KLOTHO FOR THE TREATMENT OF TYPE II DIABETES, OBESITY, AND RELATED METABOLIC DISORDERS | 2017-04-06 |
20170096463 | Modified FGF-21 Polypeptides and Their Uses | 2017-04-06 |
20170096464 | FIBROBLAST GROWTH FACTOR MUTANTS HAVING IMPROVED FUNCTIONAL HALF-LIFE AND METHODS OF THEIR USE | 2017-04-06 |
20170096465 | FIBROBLAST GROWTH FACTOR MUTANTS HAVING IMPROVED FUNCTIONAL HALF-LIFE AND METHODS OF THEIR USE | 2017-04-06 |
20170096466 | HOMOGENEOUS PREPARATIONS OF IL-31 | 2017-04-06 |
20170096467 | Peptide Analogs for Treating Diseases and Disorders | 2017-04-06 |
20170096468 | IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE | 2017-04-06 |
20170096469 | Bi-Specific Therapeutic Proteins for Tissue Repair | 2017-04-06 |
20170096470 | DUAL SPECIFIC BINDING PROTEINS HAVING A RECEPTOR SEQUENCE | 2017-04-06 |
20170096471 | SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TREATMENT OF MEDICAL DISORDERS | 2017-04-06 |
20170096472 | ALBUMIN FUSION PROTEINS | 2017-04-06 |
20170096473 | HUMAN PLACENTAL COLLAGEN COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME | 2017-04-06 |
20170096474 | Antibodies that Neutralize Botulinum Neurotoxins | 2017-04-06 |
20170096475 | SINGLE DOMAIN BINDING MOLECULE | 2017-04-06 |
20170096476 | METHODS AND COMPOSITIONS RELATED TO AMYLOID-BETA-42 OLIGOMERS | 2017-04-06 |
20170096477 | ANTI-GP73 MONOCLONAL ANTIBODIES AND METHODS OF OBTAINING THE SAME | 2017-04-06 |
20170096478 | THERAPEUTIC AGENT FOR INFLAMMATORY DISEASE | 2017-04-06 |
20170096479 | OPTIMIZED VARIANTS OF ANTI-VEGF ANTIBODIES | 2017-04-06 |
20170096480 | ANTIBODY VARIANTS | 2017-04-06 |
20170096481 | SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOR NECROSIS FACTOR-ALPHA AND USES THEREFOR | 2017-04-06 |
20170096482 | SOLUBILITY OPTIMIZATION OF IMMUNOBINDERS | 2017-04-06 |
20170096483 | Biomarkers Related to Interleukin-33 (IL-33)-Mediated Diseases and Uses Thereof | 2017-04-06 |
20170096484 | METHODS OF TREATING DISEASES WHICH ARE MEDIATED BY CUTANEOUS LYMPHOCYTE ANTIGEN POSITIVE CELLS | 2017-04-06 |
20170096485 | BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES | 2017-04-06 |
20170096486 | AGENTS INHIBITING GRANULIN FOR TREATMENT OF CANCER | 2017-04-06 |
20170096487 | ANTIBODIES SPECIFICALLY BINDING TO HER3 | 2017-04-06 |
20170096488 | HUMAN ANTIBODIES TO GFR ALPHA3 AND METHODS OF USE THEREOF | 2017-04-06 |
20170096489 | ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR AND METHODS OF USE THEREOF | 2017-04-06 |
20170096490 | AMINO ACID SEQUENCES DIRECTED AGAINST RANK-L AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF BONE DISEASES AND DISORDERS | 2017-04-06 |